MicroRNA-21 is an Antiapoptotic Factor in Human Glioblastoma Cells
Overview
Affiliations
MicroRNAs (miRNAs) are small noncoding RNA molecules that regulate protein expression by targeting the mRNA of protein-coding genes for either cleavage or repression of translation. The roles of miRNAs in lineage determination and proliferation as well as the location of several miRNA genes at sites of translocation breakpoints or deletions has led to the speculation that miRNAs could be important factors in the development or maintenance of the neoplastic state. Here we show that the highly malignant human brain tumor, glioblastoma, strongly over-expresses a specific miRNA, miR-21. Our studies show markedly elevated miR-21 levels in human glioblastoma tumor tissues, early-passage glioblastoma cultures, and in six established glioblastoma cell lines (A172, U87, U373, LN229, LN428, and LN308) compared with nonneoplastic fetal and adult brain tissues and compared with cultured nonneoplastic glial cells. Knockdown of miR-21 in cultured glioblastoma cells triggers activation of caspases and leads to increased apoptotic cell death. Our data suggest that aberrantly expressed miR-21 may contribute to the malignant phenotype by blocking expression of critical apoptosis-related genes.
MicroRNAs Expression Profile in MN1-Altered Astroblastoma.
Gianno F, Miele E, Sabato C, Ferretti E, Minasi S, Buttarelli F Biomedicines. 2025; 13(1).
PMID: 39857696 PMC: 11762140. DOI: 10.3390/biomedicines13010112.
MicroRNA-21 as a Regulator of Cancer Stem Cell Properties in Oral Cancer.
Jaksic Karisik M, Lazarevic M, Mitic D, Milosevic Markovic M, Riberti N, Jelovac D Cells. 2025; 14(2).
PMID: 39851519 PMC: 11763652. DOI: 10.3390/cells14020091.
Dwianingsih E, Hartanto R, Safitri S, Krisnugraha Y, Sianipar C, Basuki E F1000Res. 2025; 13():1361.
PMID: 39801574 PMC: 11725040. DOI: 10.12688/f1000research.153731.1.
Yamamoto K, Chiba M Exp Ther Med. 2024; 29(2):22.
PMID: 39650777 PMC: 11621913. DOI: 10.3892/etm.2024.12772.
Nieland L, Vrijmoet A, Jetten I, Rufino-Ramos D, de Reus A, Breyne K Mol Ther. 2024; 33(1):133-151.
PMID: 39563028 PMC: 11764731. DOI: 10.1016/j.ymthe.2024.11.023.